Vical Overview

  • Founded
  • 1987
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Vical General Information

Description

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Acquirer
Primary Office
  • 10390 Pacific Center Court
  • San Diego, CA 92121
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 03-Sep-2019 00000 Completed Generating Revenue
11. Secondary Transaction - Open Market 00000 Completed Generating Revenue
10. 2PO 05-Jan-2012 0000 00000 Completed Generating Revenue
9. PIPE 08-Jan-2010 0000 00000 Completed Generating Revenue
8. PIPE 30-Jul-2009 0000 000.00 Completed Generating Revenue
7. PIPE 26-May-2009 0000 000.00 Completed Generating Revenue
6. PIPE 22-May-2009 000.00 000.00 Completed Generating Revenue
5. PIPE 23-Jun-2008 000.00 000.00 Completed Generating Revenue
4. PIPE 01-Oct-2006 $12.5M $26.5M Completed Generating Revenue
3. 2PO 23-Jul-1993 $14M $14M Completed Generating Revenue
To view Vical’s complete valuation and funding history, request access »

Vical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics f
Biotechnology
San Diego, CA
00000
000000&0 00000

000000 0

onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
0000000000000
PA
000 As of 0000
000.00
00000000 000.00

00000

t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labor
0000 000000000
Paris, France
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vical Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation PA 000 000.00 00000000 000.00
00000 Formerly VC-backed Paris, France 00 00000 000000000 00000
000000 Corporation Durham, NC 00 000.00 000000000 000.00
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
You’re viewing 5 of 30 competitors. Get the full list »

Vical Executive Team (9)

Name Title Board Seat Contact Info
Adam Levy Executive
You’re viewing 1 of 9 executive team members. Get the full list »

Vical Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Azimuth Opportunity Investment Bank Minority 000 0000 000000 0
Federated Kaufmann Fund Mutual Fund Minority 000 0000 000000 0
Mentor Capital Venture Capital Minority 000 0000 000000 0
Morgenthaler Ventures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Vical Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00 01-Jun-2006 0000 000.00 Biotechnology
Inovio Pharmaceuticals 03-Jan-2006 PIPE 000.00 Biotechnology
To view Vical’s complete investments history, request access »

Vical Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00 01-Jun-2006 0000 000.00 Completed
  • 00000
Inovio Pharmaceuticals 03-Jan-2006 PIPE 000.00 Completed
  • 2 buyers
To view Vical’s complete exits history, request access »